- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Aytu BioScience is a drug manufacturers - specialty & generic business based in the US. Aytu BioScience shares (AYTU) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.16 – a decrease of 2.92% over the previous week. Aytu BioScience employs 102 staff and has a trailing 12-month revenue of around $81 million.
What's in this guide?
Our top picks for where to buy Aytu BioScience stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Aytu BioScience stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AYTU. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Aytu BioScience stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Aytu BioScience stock price (NASDAQ: AYTU)
Use our graph to track the performance of AYTU stocks over time.Aytu BioScience shares at a glance
Latest market close | $2.16 |
---|---|
52-week range | $2.04 - $3.45 |
50-day moving average | $2.42 |
200-day moving average | $2.77 |
Wall St. target price | $8.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-2.86 |
Is it a good time to buy Aytu BioScience stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aytu BioScience price performance over time
Historical closes compared with the close of $2.1648 from 2024-10-25
1 week (2024-10-21) | -2.92% |
---|---|
1 month (2024-09-27) | -8.27% |
3 months (2024-07-26) | -19.82% |
6 months (2024-04-26) | -25.46% |
1 year (2023-10-27) | -18.31% |
---|---|
2 years (2022-10-28) | 1,193.19% |
3 years (2021-10-27) | 2.38 |
5 years (2019-10-28) | 10.5 |
Is Aytu BioScience stock undervalued or overvalued?
Valuing Aytu BioScience stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aytu BioScience's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aytu BioScience's EBITDA
Aytu BioScience's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.1 million.
The EBITDA is a measure of a Aytu BioScience's overall financial performance and is widely used to measure a its profitability.
Aytu BioScience financials
Revenue TTM | $81 million |
---|---|
Gross profit TTM | $66.6 million |
Return on assets TTM | -1.06% |
Return on equity TTM | -47.24% |
Profit margin | -19.56% |
Book value | $4.64 |
Market Capitalization | $13.2 million |
TTM: trailing 12 months
Aytu BioScience share dividends
We're not expecting Aytu BioScience to pay a dividend over the next 12 months.
Have Aytu BioScience's shares ever split?
Aytu BioScience's shares were split on a 1:20 basis on 5 January 2023 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aytu BioScience shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Aytu BioScience shares which in turn could have impacted Aytu BioScience's share price.
Aytu BioScience share price volatility
Over the last 12 months, Aytu BioScience's shares have ranged in value from as little as $2.04 up to $3.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aytu BioScience's is -1.43. This would suggest that Aytu BioScience's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aytu BioScience has bucked the trend.
Aytu BioScience overview
Aytu BioPharma, Inc. , a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021.
Frequently asked questions
nullWhat percentage of Aytu BioScience is owned by insiders or institutions?
Currently 2.364% of Aytu BioScience shares are held by insiders and 33.447% by institutions. How many people work for Aytu BioScience?
Latest data suggests 102 work at Aytu BioScience. When does the fiscal year end for Aytu BioScience?
Aytu BioScience's fiscal year ends in June. Where is Aytu BioScience based?
Aytu BioScience's address is: Denver Corporate Center III, Denver, CO, United States, 80237 What is Aytu BioScience's ISIN number?
Aytu BioScience's international securities identification number is: US0547548745 What is Aytu BioScience's CUSIP number?
Aytu BioScience's Committee on Uniform Securities Identification Procedures number is: 054754205
More guides on Finder
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
SoFi Invest vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
SoFi Invest® review 2024: Simple investing, free CFP access
SoFi Invest is a commission-free platform with both active and automated investment accounts.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
-
Robinhood Review 2024: IRA Match and No Commissions
A deep dive into the highlights and limitations of Robinhood.
Ask a question